ARS successfully registered a number of products during last two months. Among them are water for injection, Timolol eye drops, Amoxicillin + Clavulanic acid combination (antibacterial, powder for suspension), Omeprazole (gastroenterology, lyophilisate for preparation of solution for intravenous administration), Peginterferon alfa-2b (treatment of chronic hepatitis C), Topiramate tablets (CNS generic). Marketing authorization holders will be Russian and Indian pharmaceutical companies.